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Deep vein thrombosis (DVT) is a significant cause of
morbidity and mortality throughout the world [1]. Risk
factors for DVT include major surgery, immobilization,
trauma, and cancer, among others [1]. Many mouse mod-
els of thrombosis have been used to study mechanisms of
thrombosis, including those involving small and large
veins. In this report from the Animal Models Subcommit-
tee of the ISTH, we summarize the strengths and weak-
nesses of the inferior vena cava (IVC) stenosis mouse
model of venous thrombosis.
History
In this model, the lumen volume of the IVC is reduced by
~ 90% [2,3]. This model was adapted from a similar rat
model called the ‘St Thomas Model’, involving IVC ste-
nosis followed by endothelial damage with vascular
clamps upstream of the stenosis site [4]. Many variants of
the St Thomas model have been described. The IVC ste-
nosis mouse model described in this article was first
reported in 2011, and does not involve a vascular damage
step [2]. Since then, several groups have used the model,
with slight variations [3,5–9]. Thrombosis in this new
model is thought to be initiated by the combination of
endothelial activation, a reduction in blood flow velocity,
and disturbed blood flow upstream of the stenosis site
[2,3].
Methods
In this model, a midline laparotomy is performed on
anesthetized male mice that are at least 8 weeks of age
and 22 g in weight [2,3,6]. The IVC is exposed by atrau-
matic blunt dissection, and the IVC is carefully separated
from the abdominal aorta. A spacer is placed on top of
the exposed IVC, and a non-reactive permanent narrow-
ing ligature (7.0 or 8.0 monofil polypropylene) is secured
around both the IVC and spacer directly below the renal
veins. The spacer is then removed, resulting in a ~ 90%
reduction in IVC lumen size at the stenosis site [2]. Injury
to the IVC wall is avoided during the procedure. Mice
with any bleeding from the IVC are excluded. The surgi-
cal site is then closed, and mice are allowed to recover
under the influence of appropriate analgesia.
Sources of variability
The spacers used for this model range from 0.26 to
0.36 mm in diameter, and consist of guide wires, sutures,
or blunted needles [2,3,5–9]. The most common spacers
used to date are a 0.36-mm guide wire [3,9] and a blunted
30-gauge needle [2,6,7]. The effect of spacer diameter and
length on thrombosis in this model has not been evalu-
ated. The method of surgical anesthesia also varies, with
an isoflurane/oxygen mixture being the most common
[2,3,5–9]. There is some debate as to whether side
branches should be ligated to control for IVC anatomy
variation. A concern with side branch ligation is that it
may result in endothelial damage and increase the dura-
tion of surgery. One group compared the size of thrombi
in mice with and without side branch ligation, and found
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no difference between the two groups [9]. This same
study, however, found that side branches that were
< 1.5 mm from the stenosis site resulted in smaller
thrombi [9].
Quantification of thrombus size
Thrombus size in this model is typically quantified by
measuring thrombus mass or size at a given time point
after the induction of stenosis. In order to obtain these
measurements, mice are euthanized and the IVC is har-
vested. We and others have extended the utility of this
model by using high-frequency ultrasonography to image
blood flow and quantify IVC thrombus growth in vivo
(Fig. 1A–C) [9].
Strengths and weaknesses of the new model
It has been well documented that human DVT is most
often initiated within the valve sinuses of large veins on
an intact endothelium [1]. A strength of this model is that
thrombosis is initiated in a large vein in the mouse in the
absence of major vessel damage. Furthermore, although
there are no valves in the IVC, the disturbed blood flow
occurring around the stenosis site may mimic changes in
blood flow that occur over valves and within valve pock-
ets in large veins in humans (Fig. 1D). The thrombi that
develop in this model are also histologically similar to
human venous thrombi [2,3].
The major concern with this model is that throm-
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Fig. 1. In vivo imaging of the inferior vena cava (IVC) stenosis model. (A, B) IVC stenosis was performed in C57Bl/6J mice, and ultrasono-
graphic imaging of the stenosis site (A) before and (B) after thrombus formation was performed. (C) Longitudinal thrombus area was mea-
sured in mice at 24 h, by ultrasonography. Thrombi were then immediately harvested and weighed. Linear regression analysis for longitudinal
thrombus area vs. thrombus mass identified a strong correlation (r2 = 0.96). (D) Color Doppler imaging reveals a pattern of disturbed blood
flow around the stenosis site prior to thrombus development.
© 2014 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis
572 J. Geddings et al
thrombosis at 48 h in wild-type mice ranges from 44% to
100% [2,5,8,9]. We have a lot of experience with this
model in our laboratory, and followed the development
and growth of thrombi in 15 C57Bl/6J mice aged 14–
18 weeks over a period of 48 h. High-frequency ultraso-
nography was used to measure thrombus size in each
mouse at 3, 6, 9 and 48 h after the initiation of thrombo-
sis (Table S1). As expected, we found that both thrombus
size at each time point and time to thrombus initiation
were variable, with thombi appearing in the IVC any-
where from 3 to 48 h after stenosis (thrombus area, inci-
dence: 3 h, 0–8.5 mm2, 13%; 6 h, 0–11.1 mm2, 33%; 9 h,
0–10.1 mm2, 40%; 48 h, 0–11.1 mm2, 53%). Another lim-
itation of this model is that it is performed in a vein that
does not have valves.
Conclusions
Like any model, this mouse model of venous thrombosis
does not accurately reflect all aspects of human DVT.
However, as discussed above, it does have certain
strengths over other available models. Primarily, the initi-
ation of thrombosis occurs without the induction of
major vascular damage, which more closely mimics
human DVT than models triggered by chemical or physi-
cal vessel damage. Nevertheless, the high variability in
thrombus development is a significant concern that limits
its utility for detecting small differences between groups.
Addendum
J. Geddings and N. Mackman wrote the manuscript, with
input from M. Aleman, A. Wolberg, M. von Br€uhl, and
S. Massberg.
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